Title : Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.

Pub. Date : 2015 Apr 7

PMID : 25852263






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Currently, insulin sensitizers (thiazolidinediones) and antioxidants (vitamin E) seem to be the most promising therapeutic agents for NAFLD/NASH, and lipid-lowering drugs, pentoxifylline, angiotensin receptor blockers, and n-3 polyunsaturated fatty acids also have promise. Fatty Acids, Omega-3 insulin Homo sapiens